A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer
dc.contributor.author | Besse, B. | |
dc.contributor.author | Barlesi, F. | |
dc.contributor.author | Demedts, I. | |
dc.contributor.author | Fuentes Pradera, J. | |
dc.contributor.author | Renault, A. | |
dc.contributor.author | Robinet, G. | |
dc.contributor.author | Frimodt-Moller, B. | |
dc.contributor.author | Gil, M. | |
dc.contributor.author | Vansteenkiste, J. | |
dc.contributor.authoraffiliation | [Besse, B.] Gustave Roussy Inst Cancerol, Dept Canc Med, Villejuif, France | |
dc.contributor.authoraffiliation | [Barlesi, F.] Aix Marseille Univ, Fac Med Nord, Marseille, France | |
dc.contributor.authoraffiliation | [Demedts, I.] AZ Delta, Roeselare, Belgium | |
dc.contributor.authoraffiliation | [Fuentes Pradera, J.] Hosp Univ Nuestra Senora Valme, Oncol, Seville, Spain | |
dc.contributor.authoraffiliation | [Renault, A.] Ctr Hosp Pau, Pau, France | |
dc.contributor.authoraffiliation | [Robinet, G.] Hop Morvan, CHU Brest, Brest, France | |
dc.contributor.authoraffiliation | [Frimodt-Moller, B.] Eli Lilly Denmark, Copenhagen, Denmark | |
dc.contributor.authoraffiliation | [Gil, M.] Eli Lilly Polska, Warsaw, Poland | |
dc.contributor.authoraffiliation | [Vansteenkiste, J.] Univ Hosp KU Leuven, Leuven, Belgium | |
dc.contributor.funder | Eli Lilly and Company | |
dc.date.accessioned | 2025-01-07T15:24:40Z | |
dc.date.available | 2025-01-07T15:24:40Z | |
dc.date.issued | 2018-04-01 | |
dc.identifier.doi | 10.1016/S1556-0864(18)30406-4 | |
dc.identifier.essn | 1556-1380 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.unpaywallURL | http://www.jto.org/article/S1556086418304064/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27119 | |
dc.identifier.wosID | 436557600127 | |
dc.issue.number | 4 | |
dc.issue.number | S | |
dc.journal.title | Journal of thoracic oncology | |
dc.journal.titleabbreviation | J. thorac. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de Valme | |
dc.page.number | S76-S76 | |
dc.publisher | Elsevier science inc | |
dc.rights.accessRights | open access | |
dc.title | A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 13 | |
dc.wostype | Meeting Abstract |